Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.
Press releases published on September 5, 2025
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
-- The 2025 DREAMS Grant Program awards $50,000 each to two non-profit organizations working to advance equity, accessibility and inclusion for those living with Duchenne in the U.S., EU or U.K. -- -- Announced in advance of World Duchenne Awareness Day on …
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
- Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment - - 90% of 12-month …
Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
TORONTO and HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage cancer immunotherapy company focused on the development of Superkines, announced today that Dr. …
AAVantgarde presents updated positive clinical data from its AAVB-081 program for Usher 1B at EURetina 2025
MILAN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated clinical data from the …
Akari Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
BOSTON and LONDON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that Abizer Gaslightwala, President and Chief …
Wrap Technologies and STORM Training Group Partner to Deliver Post-BolaWrap® Arrest & Control Training via WrapTactics™
MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (the “Company” or “Wrap”), a leader in pre-escalation and public safety solutions, today announced a strategic partnership with STORM Training Group, a Minnesota-based …
3 Lucky Players Share $180,000 in the9bit’s August Fiesta Finale
Singapore, Sept. 05, 2025 (GLOBE NEWSWIRE) -- the9bit, an innovative gaming platform backed by The9 Limited (NASDAQ: NCTY), has concluded its $1 Million August Fiesta campaign, awarding $180,000 in the grand finale airdrop to 3 winners. Running throughout …
Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference
LOUISVILLE, Colo., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced Robin Cowie, Chief Financial Officer, will host in-person 1x1 investor meetings at Lake Street Capital Markets’ 9th …
FlowReel Unveils the Next Evolution in AI-Powered Creative Production, Empowering Global Content Innovation
HONG KONG, Sept. 05, 2025 (GLOBE NEWSWIRE) -- FlowReel, the pioneer in video creation, has launched an all-in-one AI creative toolkit to raise the bar for video, image and audio content creation in the digital world. The trailblazing creative force …
RHEA Essentials Inositol Returns for Hormonal Support
VILNIUS, Lithuania, Sept. 05, 2025 (GLOBE NEWSWIRE) -- After months of being sold out, RHEA Essentials Inositol is finally returning, and people are already talking about it. Known for supporting hormonal balance, metabolic health, and emotional well-being …
Iana TORRES rejoint le groupe Videlio au poste de Directrice Marketing et Communication
Videlio, acteur de référence de l’intégration audiovisuelle, complète son équipe de Direction. Cette nomination s’inscrit dans un contexte de très forte accélération pour le groupe en France comme à l’international. Rattachée à la Direction Générale, Iana …
Tensive annuncia aggiornamenti clinici positivi che evidenziano il potenziale del dispositivo REGENERA™ / SOFTAG™ per la ricostruzione del seno post-lumpectomia
I dati clinici provenienti da due studi in corso su pazienti sottoposte a lumpectomia confermano il profilo di sicurezza e i crescenti benefici prestazionali del dispositivo Gli obiettivi primari di sicurezza e secondari di efficacia sono stati raggiunti …
Tensive provides positive clinical updates highlighting potential of REGENERA™ / SOFTAG™ device to transform post-cancer breast reconstruction
Clinical data from two ongoing trials in patients undergoing lumpectomy confirm strong safety profile and growing performance benefits of device Primary safety and secondary performance objectives met in interim analysis of 25 patients in pivotal trial, …
Aduro Clean Technologies nimmt an Konferenzen im September teil und startet PR-Kampagne
LONDON, Ontario, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen für saubere Technologien, das die Kraft der Chemie nutzt, um minderwertige Rohstoffe …
Aduro Clean Technologies participera à des conférences en septembre et lancera une campagne de relations publiques
LONDON, Ontario, 05 sept. 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (« Aduro » ou la « Société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société de technologies propres qui utilise le pouvoir de la chimie pour transformer des matières …
HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be …